Rhabdomyolysis in a patient receiving the combination of cerivastatin and gemfibrozil

被引：38

作者：

Bermingham, RP

Whitsitt, TB

Smart, ML

Nowak, DP

Scalley, RD

机构：

[1] Ft Collins Family Med Residency Program, Ft Collins, CO USA

[2] Heart & Vasc Clin No Colorado, Ft Collins, CO USA

[3] Yuma Clin, Yuma, CO USA

[4] Univ Wyoming, Sch Pharm, Laramie, WY 82071 USA

来源：

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2000年 / 57卷 / 05期

关键词：

D O I：

10.1093/ajhp/57.5.461

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：461 / 464

页数：4

共 27 条

[1] A brief review paper of the efficacy and safety of atorvastatin in early clinical trials [J].

BakkerArkema, RG ;

Best, J ;

Fayyad, R ;

Heinonen, TM ;

Marais, AD ;

Nawrocki, JW ;

Black, DM .

ATHEROSCLEROSIS, 1997, 131 (01) :17-23

[2] Preclinical and clinical pharmacology of cerivastatin [J].

Bischoff, H ;

Heller, AH .

AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (4B) :18J-25J

[3] Cerivastatin: pharmacology of a novel synthetic and highly active HMG-CoA reductase inhibitor [J].

Bischoff, H ;

Angerbauer, R ;

Bender, J ;

Bischoff, E ;

Faggiotto, A ;

Petzinna, D ;

Pfitzner, J ;

Porter, MC ;

Schmidt, D ;

Thomas, G .

ATHEROSCLEROSIS, 1997, 135 (01) :119-130

[4] An overview of the clinical safety profile of atorvastatin (Lipitor), a new HMG-CoA reductase inhibitor [J].

Black, DM ;

Bakker-Arkema, RG ;

Nawrocki, JW .

ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (06) :577-584

[5] EXPANDED CLINICAL-EVALUATION OF LOVASTATIN (EXCEL) STUDY RESULTS .1. EFFICACY IN MODIFYING PLASMA-LIPOPROTEINS AND ADVERSE EVENT PROFILE IN 8245 PATIENTS WITH MODERATE HYPERCHOLESTEROLEMIA [J].

BRADFORD, RH ;

SHEAR, CL ;

CHREMOS, AN ;

DUJOVNE, C ;

DOWNTON, M ;

FRANKLIN, FA ;

GOULD, AL ;

HESNEY, M ;

HIGGINS, J ;

HURLEY, DP ;

LANGENDORFER, A ;

NASH, DT ;

POOL, JL ;

SCHNAPER, H .

ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (01) :43-49

[6] EXPANDED CLINICAL-EVALUATION OF LOVASTATIN (EXCEL) STUDY RESULTS .3. EFFICACY IN MODIFYING LIPOPROTEINS AND IMPLICATIONS FOR MANAGING PATIENTS WITH MODERATE HYPERCHOLESTEROLEMIA [J].

BRADFORD, RH ;

SHEAR, CL ;

CHREMOS, AN ;

FRANKLIN, FA ;

NASH, DT ;

HURLEY, DP ;

DUJOVNE, CA ;

POOL, JL ;

SCHNAPER, H ;

HESNEY, M ;

LANGENDORFER, A .

AMERICAN JOURNAL OF MEDICINE, 1991, 91 :S18-S24

[7]

CHICHMANIAN RM, 1991, ANN MED INTERNE, V142, P587

[8] Clinical efficacy and safety of cerivastatin: Summary of pivotal phase IIb/III studies [J].

Davignon, J ;

Hanefeld, M ;

Nakaya, N ;

Hunninghake, DB ;

Insull, W ;

Ose, L .

AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (4B) :32J-39J

[9] Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia [J].

Ellen, RLB ;

McPherson, R .

AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (4A) :60B-65B

[10]

ENDO A, 1992, J LIPID RES, V33, P1569

← 1 2 3 →